{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:23:25Z","timestamp":1768537405513,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00280-017-3408-4","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T07:30:17Z","timestamp":1501572617000},"page":"623-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-8379","authenticated-orcid":false,"given":"Sergey S.","family":"Gordeyev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsen O.","family":"Rasulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera A.","family":"Gorbounova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey I.","family":"Tkachev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriya V.","family":"Glebovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5615-7806","authenticated-orcid":false,"given":"Mikhail Yu.","family":"Fedyanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya S.","family":"Besova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia E.","family":"Surayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"issue":"3","key":"3408_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354\u2013356","journal-title":"Dis Colon Rectum"},{"issue":"9034","key":"3408_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","year":"1996","unstructured":"UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348(9034):1049\u20131054","journal-title":"Lancet"},{"issue":"5","key":"3408_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol Off J Am Soc Clin Oncol 15(5):2040\u20132049","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"3408_CR4","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol Off J Am Soc Clin Oncol 14(9):2527\u20132539","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"3408_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial. Lancet Oncol 14(6):516\u2013524. doi:10.1016\/S1470-2045(13)70086-X","journal-title":"Lancet Oncol"},{"issue":"35","key":"3408_CR6","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol Off J Am Soc Clin Oncol 30(35):4344\u20134351. doi:10.1200\/JCO.2012.43.8085","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3408_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1748-717X-9-124","volume":"9","author":"G Thind","year":"2014","unstructured":"Thind G, Johal B, Follwell M, Kennecke HF (2014) Chemoradiation with capecitabine and mitomycin-C for stage I\u2013III anal squamous cell carcinoma. Radiat Oncol 9:124. doi:10.1186\/1748-717X-9-124","journal-title":"Radiat Oncol"},{"issue":"9","key":"3408_CR8","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/bjc.2014.467","volume":"111","author":"D Meulendijks","year":"2014","unstructured":"Meulendijks D, Dewit L, Tomasoa N, van Tinteren H, Beijnen J, Schellens J, Cats A (2014) Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Br J Cancer 111(9):1726\u20131733","journal-title":"Br J Cancer"},{"issue":"1","key":"3408_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","volume":"72","author":"R Glynne-Jones","year":"2008","unstructured":"Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D (2008) EXTRA\u2014a multicenter phase II study of chemoradiation using a 5\u00a0day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 72(1):119\u2013126. doi:10.1016\/j.ijrobp.2007.12.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3408_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.radonc.2015.08.015","volume":"117","author":"EC White","year":"2015","unstructured":"White EC, Goldman K, Aleshin A, Lien WW, Rao AR (2015) Chemoradiotherapy for squamous cell carcinoma of the anal canal: comparison of one versus two cycles mitomycin-C. Radiother Oncol 117(2):240\u2013245","journal-title":"Radiother Oncol"},{"issue":"6","key":"3408_CR11","first-page":"1419","volume":"24","author":"A Saito Ramalho","year":"2010","unstructured":"Saito Ramalho A, Dantas Lopes A, Talans A, Parlato Sakiyama BY, Stelko Pereira GL, Hoff PM, De Castro G Jr (2010) Molecular targets for therapeutic interventions in human papillomavirus-related cancers (review). Oncol Rep 24(6):1419\u20131426","journal-title":"Oncol Rep"},{"issue":"9","key":"3408_CR12","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/1097-0142(20011101)92:9<2334::AID-CNCR1580>3.0.CO;2-3","volume":"92","author":"JI Clark","year":"2001","unstructured":"Clark JI, Hofmeister C, Choudhury A, Matz G, Collins S, Bastian R, Melian E, Emami B, Petruzzelli G (2001) Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma. Cancer 92(9):2334\u20132340","journal-title":"Cancer"},{"issue":"4","key":"3408_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1200\/JCO.2001.19.4.1088","volume":"19","author":"AA Forastiere","year":"2001","unstructured":"Forastiere AA, Leong T, Rowinsky E, Murphy BA, Vlock DR, DeConti RC, Adams GL (2001) Phase III comparison of high-dose paclitaxel\u00a0+\u00a0cisplatin\u00a0+\u00a0granulocyte colony-stimulating factor versus low-dose paclitaxel\u00a0+\u00a0cisplatin in advanced head and neck cancer: eastern Cooperative Oncology Group Study E1393. J Clin Oncol Off J Am Soc Clin Oncol 19(4):1088\u20131095","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"3408_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/COC.0b013e31819d369d","volume":"33","author":"M Moreno-Jimenez","year":"2010","unstructured":"Moreno-Jimenez M, Valero J, Lopez-Picazo JM, Arbea L, Aristu J, Cambeiro M, Alcalde J, Martinez-Monge R (2010) Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules. Am J Clin Oncol 33(2):137\u2013143. doi:10.1097\/COC.0b013e31819d369d","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"3408_CR15","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/annonc\/mdf268","volume":"13","author":"R Hitt","year":"2002","unstructured":"Hitt R, Paz-Ares L, Brandariz A, Castellano D, Pena C, Millan JM, Calvo F, Ortiz de Urbina D, Lopez E, Alvarez-Vicent JJ, Cortes-Funes H (2002) Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial. Ann Oncol Off J Eur Soc Med Oncol ESMO 13(10):1665\u20131673","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"issue":"10","key":"3408_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/sj.bjc.6603134","volume":"94","author":"E van Meerten","year":"2006","unstructured":"van Meerten E, Muller K, Tilanus HW, Siersema PD, Eijkenboom WM, van Dekken H, Tran TC, van der Gaast A (2006) Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer 94(10):1389\u20131394. doi:10.1038\/sj.bjc.6603134","journal-title":"Br J Cancer"},{"issue":"4","key":"3408_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00130404-200307000-00007","volume":"9","author":"AA Meluch","year":"2003","unstructured":"Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD (2003) Preoperative therapy with concurrent paclitaxel\/carboplatin\/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J 9(4):251\u2013260","journal-title":"Cancer J"},{"issue":"2","key":"3408_CR18","doi-asserted-by":"publisher","first-page":"205 e201","DOI":"10.1016\/j.ajog.2007.04.047","volume":"197","author":"R Higgins","year":"2007","unstructured":"Higgins R, Bussey M, Naumann W, Hall J, Tait D, Haake M (2007) Concurrent carboplatin and paclitaxel with pelvic radiation therapy in the primary treatment of cervical cancer. Am J Obstet Gynecol 197(2):205 e201\u2013205 e201. doi:10.1016\/j.ajog.2007.04.047 \n                           (discussion 205 e205\u2013207)","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"3408_CR19","first-page":"4637","volume":"31","author":"A Abbas","year":"2011","unstructured":"Abbas A, Nehme E, Fakih M (2011) Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapy. Anticancer Res 31(12):4637\u20134640","journal-title":"Anticancer Res"},{"issue":"7","key":"3408_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00384-008-0467-3","volume":"23","author":"T Alcindor","year":"2008","unstructured":"Alcindor T (2008) Activity of paclitaxel in metastatic squamous anal carcinoma. Int J Colorectal Dis 23(7):717. doi:10.1007\/s00384-008-0467-3","journal-title":"Int J Colorectal Dis"},{"key":"3408_CR21","doi-asserted-by":"crossref","unstructured":"Byer J, Mahipal A, Dinwoodie WR, Almhanna K, Shibata D, Kim RD (2013) Efficacy of carboplatin and paclitaxel therapy in patients with advanced squamous cell carcinoma (SCC) of the anal canal. J Clin Oncol (Meet Abstract) 31 (suppl 4) (abstr 539)","DOI":"10.1200\/jco.2013.31.4_suppl.539"},{"issue":"2","key":"3408_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000361051","volume":"87","author":"R Kim","year":"2014","unstructured":"Kim R, Byer J, Fulp WJ, Mahipal A, Dinwoodie W, Shibata D (2014) Carboplatin and paclitaxel treatment is effective in advanced anal cancer. Oncology 87(2):125\u2013132","journal-title":"Oncology"},{"issue":"2","key":"3408_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.radonc.2012.06.006","volume":"104","author":"D Sebag-Montefiore","year":"2012","unstructured":"Sebag-Montefiore D, Meadows HM, Cunningham D, Plowman PN, Hurman DC, Davidson N, Grieve R, Levine E, Glynne-Jones R (2012) Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin. Radiother Oncol J Eur Soc Ther Radiol Oncol 104(2):155\u2013160. doi:10.1016\/j.radonc.2012.06.006","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"3408_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e31827e52a3","author":"MP Mitchell","year":"2013","unstructured":"Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P (2013) Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Am J Clin Oncol. doi:10.1097\/COC.0b013e31827e52a3","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"3408_CR25","first-page":"39","volume":"6","author":"MD Chuong","year":"2013","unstructured":"Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, Dinwoodie W, Rao N, Meredith KL, Shridhar R (2013) Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal. Gastrointest Cancer Res GCR 6(2):39\u201345","journal-title":"Gastrointest Cancer Res GCR"},{"key":"3408_CR26","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2011","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2011) TNM classification of malignant tumours. Wiley, Hoboken"},{"issue":"3","key":"3408_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74(3):824","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3408_CR28","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf. Accessed 1 June 2015"},{"issue":"12","key":"3408_CR29","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1200\/JCO.1990.8.12.1935","volume":"8","author":"WM Hryniuk","year":"1990","unstructured":"Hryniuk WM, Goodyear M (1990) The calculation of received dose intensity. J Clin Oncol Off J Am Soc Clin Oncol 8(12):1935\u20131937","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"3408_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ygyno.2004.09.009","volume":"96","author":"GG Rao","year":"2005","unstructured":"Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL (2005) Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecol Oncol 96(1):168\u2013172. doi:10.1016\/j.ygyno.2004.09.009","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3408_CR31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ijrobp.2006.10.027","volume":"67","author":"BG Czito","year":"2007","unstructured":"Czito BG, Kelsey CR, Hurwitz HI, Willett CG, Morse MA, Blobe GC, Fernando NH, D\u2019Amico TA, Harpole DH, Honeycutt W, Yu D, Bendell JC (2007) A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 67(4):1002\u20131007. doi:10.1016\/j.ijrobp.2006.10.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3408_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86(1):27\u201333. doi:10.1016\/j.ijrobp.2012.09.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3408_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","volume":"82","author":"LA Kachnic","year":"2012","unstructured":"Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, Willins JD, Ryan DP, Hong TS (2012) Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 82(1):153\u2013158. doi:10.1016\/j.ijrobp.2010.09.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3408_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","volume":"90","author":"K Han","year":"2014","unstructured":"Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, Brierley J, Wong R, Dinniwell R, Bayley AJ, Dawson LA, Ringash J, Krzyzanowska MK, Moore MJ, Chen EX, Easson AM, Kassam Z, Cho C, Kim J (2014) Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. Int J Radiat Oncol Biol Phys 90(3):587\u2013594. doi:10.1016\/j.ijrobp.2014.06.061","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"3408_CR35","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00280-016-3185-5","volume":"78","author":"IH Lee","year":"2016","unstructured":"Lee IH, Lee SJ, Kang BW, Chae YS, Baek D, Hwang S, Kim HJ, Park SY, Park JS, Choi GS (2016) Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer. Cancer Chemother Pharmacol 78(6):1263\u20131267","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-017-3408-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:44:20Z","timestamp":1659059060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-017-3408-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3408"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3408-4","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]},"assertion":[{"value":"28 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}